Caloric excess and sedentary lifestyle have led to a global epidemic of obesity and
metabolic syndrome. The hepatic consequence of metabolic syndrome and obesity …

Due to an increase in the obesity-associated metabolic syndrome of epidemic proportions,
nonalcoholic fatty liver disease (NAFLD) is becoming a leading cause of hepatocellular …

In light of a global rise in obesity and type 2 diabetes, non-alcoholic fatty liver disease
(NAFLD) and non-alcoholic steatohepatitis (NASH) represent an increasingly important …

The liver is the central metabolic organ of the body, regulating energy and lipid metabolism,
while also having potent immunological functions. Overwhelming the metabolic capacity of …

Non-alcoholic fatty liver disease (NAFLD) and its advanced complication, non-alcoholic
steatohepatitis (NASH), have become leading causes of hepatocellular carcinoma (HCC) …

Non-alcoholic liver disease (NAFLD) defines liver abnormalities ranging from simple
steatosis to nonalcoholic steatohepatitis with or without cirrhosis development, occurring in …

Non-alcoholic fatty liver disease (NAFLD) has emerged as the most common liver disorder
worldwide mainly attributed to the epidemic spread of obesity and type 2 diabetes mellitus …

NAFLD affects a large proportion of the US population and its incidence and prevalence are
increasing to epidemic proportions around the world. As with other liver diseases that cause …

Non-alcoholic fatty liver disease (NAFLD) is projected to become the leading cause of
hepatocellular carcinoma (HCC) in many countries. Many risk factors for NAFLD are also …

Nonalcoholic fatty liver disease (NAFLD) is considered the most common liver disorder
worldwide, affecting 25.2% of the general population. In fact, NAFLD is among the most …